Category Archives: ARV

  1. IAS 2011 HIV Prevention Research Roadmap

    Via our friends at AVAC. Where: Rome, Italy When: July 17 – July 20, 2011 The IAS Conference on HIV Pathogenesis, Treatment and Prevention is held every two years, and this year it will take place in Rome, July 17-20. The 2011 conference has a program that includes many sessions on a range of HIV-related topics. AVAC Read More >>

    ARV, ARVs, AVAC, HIV transmission, HIV/AIDS, IAS, IAS 2011, new prevention technologies, PrEP, Rome
  2. Project Inform Reports: Financing Recommendations for PrEP

    Project Inform recently released a report titled Financing and Delivery Mechanisms to Increase Pre-Exposure Prophylaxis (PrEP) Access in Populations at High-Risk of HIV Infection. Available here, the report discusses issues related to financing for PrEP to ensure that it becomes a viable, accessible prevention method for MSM. Here as an excerpt from the executive summary of the Read More >>

    ARV, ARVs, Gilead, HIV/AIDS, HIV/AIDS policy, HIV/AIDS. pre-exposure prophylaxis, PrEP, Truvada
  3. AIDS Summit at the UN: Not Enough Talk About Sex

    Via the Huffington Post, by Evelyn Leopold. World leaders gathered at the United Nations to mark the 30th anniversary of the HIV/AIDS epidemic and put out a 102-paragraph declaration. Adrienne Germain, the president of the International Women’s Health Coalition (IWHC), has been working on women’s issues all her adult life and was active in the 1994 Cairo Read More >>

    ARV, ARVs, family planning, HIV/AIDS, HIV/AIDS policy, MSM, sex work, United Nations
  4. WHO Announces New HIV Strategy for 2011-2015

    by Aldona Martinka According to a news release from the United Nations’ website, the five year strategy that the World Health Organization announced yesterday could prevent as many as 4.2 million new HIV infections and save as many as 2 million lives. The strategy for the coming years focuses on four strategic directions: “To optimize HIV prevention, diagnosis, Read More >>

    ARV, Geneva, HIV/AIDS, Microbicides, PrEP, WHO
  5. KENYA: Protest as government grapples with HIV funding shortages

    via PlusNews Hundreds of Kenyan AIDS activists held a protest on 18 May in the capital, Nairobi to demand that the government meet its commitment to increase annual health and HIV funding. “The Minister of Finance promised an annual budgetary allocation increase of 10 percent to health and HIV – we demand that this promise be kept,” Read More >>

    Africa, ARV, funding, HIV/AIDS policy, Kenya, Treatment
  6. NEWS ROUNDUP: Early HIV Treatment Can Reduce Transmission Risk By 96%, Study Results Show

    via Kaiser Family Foundation Results from a multicountry clinical trial, sponsored by the National Institute for Allergy and Infectious Diseases (NIAID), show that HIV-positive people who take combination antiretroviral therapy (ART) can reduce the risk of transmitting the virus to their HIV-negative partners by 96 percent, U.S. researchers announced on Thursday “[i]n what is being hailed as Read More >>

    ARV, ARVs, couples, heterosexual epidemic, HIV/AIDS policy, research, Treatment
  7. ARVs Dramatically Reduce Risk of Passing HIV to Healthy Partners

    via Health Behavior News Service, by Glenda Fauntleroy When one partner in a couple is infected with HIV and the other is not, treatment with antiretroviral drugs can dramatically lower the chances of the infected partner passing along the disease to his or her mate, a new evidence review finds. Patients with HIV receive a combination of Read More >>

    ARV, ARVs, couples, HIV/AIDS policy, Treatment
  8. Starting HIV treatment when CD4 cell count dips below 500 improves AIDS-free survival

    Via aidsmap, by Michael Carter Patients who start antiretroviral therapy when their CD4 cell count dipped below 500 cells/mm3 are less likely to develop an AIDS-defining illness than individuals who start treatment with a CD4 cell count of 350 cells/mm3, an international team of investigators report in the Annals of Internal Medicine. However, initiating HIV treatment with Read More >>

    antiretroviral therapy, ARV, CD4, clinical trials, HIV/AIDS, Treatment
  9. Is Africa ready for PrEP?

    Via Incidence0.org, by Adebisi Ademola Alimi One of the biggest breakthrough in HIV clinical research, since the outbreak of the epidemic 30 years ago, is the recent success in a clinical trial of a new HIV prevention approach based on the daily use of the antiretroviral drug Truvada by HIV negative person to prevent HIV transmission (Called Read More >>

    antiretroviral therapy, ARV, clinical trials, heterosexual epidemic, HIV Prevention Justice Alliance, HIV/AIDS, Infections, iPrEx, PrEP, research, Truvada
  10. AFRICA: Need for systematic HIV drug resistance testing

     via PlusNews HIV is a tough enough diagnosis, but when one contracts a strain of HIV resistant to some life-prolonging medicines, treatment options are limited. A new study has found that transmitted HIV drug resistance may be on the rise in Africa, and the authors warn that unless resistance surveillance is increased, the continent’s treatment programmes could suffer. Read More >>

    Africa, ARV, HIV/AIDS, HIV/AIDS policy, Kenya, resistance